Literature DB >> 10686589

Roles of neuregulin in synaptogenesis between mossy fibers and cerebellar granule cells.

M Ozaki1, K Tohyama, H Kishida, A Buonanno, R Yano, T Hashikawa.   

Abstract

Neuregulins (NRGs), a large group of structurally related signaling proteins, are likely to have important roles in the development, maintenance and repair of the nervous system and other selected tissues. We have demonstrated, by using the major form of NRG cloned from the mouse cerebellum that both the soluble form and the membrane anchored form of NRG may serve different functions in synaptogenesis. The soluble form of NRG was produced by proteolytic cleavage of the membrane anchored form of NRG. The proteolytic cleavage was promoted by protein kinase activation. The cleaved form of NRG trans-synaptically regulated the expression of the NMDA (N-methyl-D-aspartate) receptor subunit NR2C as neurally-derived factors, whereas the membrane anchored form of NRG showed a homophilic binding activity between NRGbeta1s. In adult mice the membrane anchored form of NRG was concentrated in neuro-terminals of both granule cells and pontocerebellar mossy fibers. The fact that NRG can be functionally viewed as cell recognition molecules as well as neurotrophic agents suggests new possibilities for the important class of molecules. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686589     DOI: 10.1002/(SICI)1097-4547(20000301)59:5<612::AID-JNR4>3.0.CO;2-V

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

Review 1.  Neuregulin signaling via erbB receptor assemblies in the nervous system.

Authors:  Sean Murphy; Randy Krainock; Muly Tham
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

2.  Neuregulin-1 at synapses on phrenic motoneurons.

Authors:  Amine N Issa; Wen-Zhi Zhan; Gary C Sieck; Carlos B Mantilla
Journal:  J Comp Neurol       Date:  2010-10-15       Impact factor: 3.215

3.  Differential regulation of neuregulin 1 expression by progesterone in astrocytes and neurons.

Authors:  Michael L Lacroix-Fralish; Vivianne L Tawfik; Nancy Nutile-McMenemy; Brent T Harris; Joyce A Deleo
Journal:  Neuron Glia Biol       Date:  2006-11

4.  Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism.

Authors:  M Shibuya; E Komi; R Wang; T Kato; Y Watanabe; M Sakai; M Ozaki; T Someya; H Nawa
Journal:  J Neural Transm (Vienna)       Date:  2010-06-05       Impact factor: 3.575

5.  Molecular and cellular characterization of Neuregulin-1 type IV isoforms.

Authors:  Alon Shamir; Andres Buonanno
Journal:  J Neurochem       Date:  2010-03-10       Impact factor: 5.372

6.  Sex differences in lumbar spinal cord gene expression following experimental lumbar radiculopathy.

Authors:  Michael L LaCroix-Fralish; Vivianne L Tawfik; Kevin F Spratt; Joyce A DeLeo
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 7.  Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders.

Authors:  R Gao; P Penzes
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

8.  Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia.

Authors:  Yonggang Li; Zhenfeng Xu; Gregory D Ford; Dajoie R Croslan; Tariq Cairobe; Zhenzhong Li; Byron D Ford
Journal:  Brain Res       Date:  2007-09-22       Impact factor: 3.252

9.  The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.

Authors:  Bo Li; Ran-Sook Woo; Lin Mei; Roberto Malinow
Journal:  Neuron       Date:  2007-05-24       Impact factor: 17.173

10.  Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia.

Authors:  Andrea Schmitt; Jiri Koschel; Mathias Zink; Manfred Bauer; Clemens Sommer; Josef Frank; Jens Treutlein; Thomas Schulze; Thomas Schneider-Axmann; Eleni Parlapani; Marcella Rietschel; Peter Falkai; Fritz A Henn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-05-12       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.